LH · Labcorp Holdings Inc.
$271.472026-07-21Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$124
-54.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($124 · $127) Analysts Range ($300 · $334) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $12.2B | — | 6.0% | 32.6% | $489MM | −$1.3B | −$847MM | 8.0% | — | 3.7% | $13.1B | $5.04 | — |
| 2024.Q4 | $12.2B | 0.0% | 6.0% | 22.1% | $565MM | −$787MM | −$223MM | 8.5% | — | 4.3% | $13.1B | $5.04 | — |
| 2025.Q1 | $13.0B | 7.0% | 8.4% | 21.9% | $848MM | −$552MM | $297MM | 8.4% | — | 6.3% | $13.7B | $9.00 | — |
| 2025.Q4 | $13.0B | 0.0% | 8.4% | 20.7% | $861MM | −$861MM | $0MM | 8.5% | — | 6.1% | $14.6B | $9.00 | — |
| 2026.Q1 | $14.1B | 8.7% | 11.0% | 18.2% | $1.3B | −$907MM | $370MM | 8.1% | — | 8.9% | $14.3B | $11.36 | 14.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.7% |
| 2027.Q1 | $14.9B | +5.2% | 10.8% | 18.4% | $1.3B | −$761MM | $556MM | 8.1% | $514MM | 9.0% | $15.0B | $15.88 | 17.1 |
| 2028.Q1 | $15.6B | +4.8% | 11.2% | 18.5% | $1.4B | −$749MM | $673MM | 8.2% | $576MM | 9.2% | $15.8B | $17.16 | 15.8 |
| 2029.Q1 | $16.4B | +5.1% | 11.8% | 18.7% | $1.6B | −$847MM | $727MM | 8.2% | $575MM | 9.7% | $16.6B | $18.99 | 14.3 |
| 2030.Q1 | $17.2B | +4.9% | 12.6% | 18.9% | $1.8B | −$884MM | $867MM | 8.3% | $633MM | 10.3% | $17.5B | $21.12 | 12.9 |
| 2031.Q1 | $18.0B | +4.8% | 12.6% | 19.1% | $1.8B | −$922MM | $909MM | 8.3% | $612MM | 10.2% | $18.4B | $22.08 | 12.3 |
|
| Term. Yr+ | $23.2B | 4.1% | 10.9% | 20.0% | $2.0B | −$962MM | $1.1B | 8.6% | $10.5B | 8.6% | — | — | — |
Active scenario IV: $124 (-54.3% vs market)